Melanoma News


Melanoma Perspective

  • Rare Melanomas Prove 'Hard to Get' Using Immunotherapy   Dr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma.
  • The Puzzling Prognostic Effect of LDH in Melanoma   Although LDH is a negative prognostic factor in melanoma, patients who receive checkpoint inhibitors may still have responses of long duration even when their LDH level is high.